10/24/2024
Congrats to sister company Ad Astra Diagnostics on a federal contract from BARDA with the potential to reach $12.6 million! This funding supports development of their next-gen QScout CBC diagnostic system, designed to be the fastest need-to-result complete blood count with special features to detect severe infections like sepsis earlier.
Stay tuned for more OneHealth advancements!
https://www.prnewswire.com/news-releases/aad-awarded-barda-contract-to-develop-next-gen-cbc-sepsis-diagnostic-system-302285132.html?tc=eml_cleartimehn